Results 171 to 180 of about 10,075,656 (346)

Publications /

open access: yes
Latest issue consulted: 1980.Description based on: 1980; title from caption.Mode of access: Internet.Annual cumulation of: Publications (Pacific Southwest Forest and Range Experiment Station (Berkeley, Calif. : Quarterly),
Pacific Southwest Forest and Range Experiment Station (Berkeley, Calif.)
core  

[Publications]

open access: yes, 1913
To The Press, Herewith is brief resume of the first quarter's operation of the new state printing law -- To The Taxpayers of Oregon, The following is from our second quarterly report to the State Printing Board ...

core  

Finding novel vulnerabilities of hypomorphic BRCA1 alleles

open access: yesMolecular Oncology, EarlyView.
Synthetic lethality screens performed to identify novel vulnerabilities often model complete gene loss, thereby overlooking patient‐derived hypomorphic mutations. In this study, we have performed genome‐wide CRISPR screens on BRCA1 hypomorphic mutations, showing BRCA1I26A behaves like wild‐type, while BRCA1R1699Q mimics deficiency. Furthermore, we have
Anne Schreuder   +10 more
wiley   +1 more source

Collaboration in Iranian Scientific Publications

open access: yes, 2002
This study looks at international collaboration in Iranian scientific publications through the ISI Science Citation Index® (SCI) for the years 1995-1999, inclusive.
WILSON, CONCEPCIÓN S., Osareh, Farideh
core  

Longitudinal genome‐wide aneuploidy measurements in circulating cell‐free DNA to predict lack of benefit from pembrolizumab in patients with metastatic urothelial cancer

open access: yesMolecular Oncology, EarlyView.
Many patients with urothelial cancer do not benefit from treatment with pembrolizumab, while at risk of severe side effects. Changes in the levels of circulating tumor DNA early during treatment, measured by a simple and affordable assay that can be easily implemented in the clinic, can be used as a prognostic tool to identify these patients.
Youssra Salhi   +14 more
wiley   +1 more source

Home - About - Disclaimer - Privacy